High ankle-brachial index participants experienced similar long-term mortality as peripheral artery disease in a national sample of community-dwelling adults.

Autor:	Parmar GM; Section of Vascular Medicine, Massachusetts General Hospital, Boston, MA. Electronic address: gmparmar@mgh.harvard.edu., Tanikella R; Hospital Medicine Program, Beth Israel Deaconess Medical Center, Boston, MA., Gupta K; Department of Cardiovascular Medicine, Kansas University Medical Center, Kansas City, KS., Dicks AB; Department of Vascular Surgery, Prisma Health, University of South Carolina School of Medicine, Greenville, SC., Sakhuja R; Section of Vascular Medicine, Massachusetts General Hospital, Boston, MA., Schainfeld R; Section of Vascular Medicine, Massachusetts General Hospital, Boston, MA., Dua A; Division of Vascular Surgery and Endovascular Therapy, Massachusetts General Hospital, Boston, MA., Weinberg I; Section of Vascular Medicine, Massachusetts General Hospital, Boston, MA.
Jazyk:	angličtina
Zdroj:	Journal of vascular surgery [J Vasc Surg] 2024 Oct; Vol. 80 (4), pp. 1251-1259. Date of Electronic Publication: 2024 Jun 10.
DOI:	10.1016/j.jvs.2024.06.005
Abstrakt:	Background: Only a few small studies have shown the association between high ankle-brachial pressure index (ABI >1.4) and adverse cardiovascular (CV) events and mortality. Although there is abundant literature depicting the association between ABI and overall systemic atherosclerosis, it typically focuses on low ABI. Furthermore, historically, many studies focusing on peripheral artery disease have excluded high ABI participants. We aimed to study the mortality outcomes of persons with high ABI in the National Health and Nutrition Examination Survey (NHANES). Methods: We obtained ABI from participants aged ≥40 years for survey years 1999 to 2004. We defined low a ABI as ≤0.9, normal ABI as 0.9 to 1.4, and high ABI as >1.4 or if the ankle pressures were >245 mm Hg. Demographics, various comorbidities, and laboratory test results were obtained at the time of the survey interview. Multivariable adjusted hazard ratios (HRs) along with 95% confidence intervals (CIs) were calculated for CV and all-cause mortality via Cox proportional hazards regression. Mortality was linked to all NHANES participants for follow-up through December 31, 2019, by the Centers for Disease Control and Prevention. Results: We identified 7639 NHANES participants with available ABI. Of these, 6787 (89%) had a normal ABI, 646 (8%) had a low ABI, and 206 (3%) had elevated ABI. Of participants with high ABI, 50% were men, 15% were African Americans, 10% were current smokers, 56% had hypertension, 33% had diabetes, 15% had chronic kidney disease (CKD), and 18% had concomitant coronary artery disease (CAD). Diabetes (odds ratio [OR], 2.4; 95% CI, 1.7-3.2), CAD (OR, 1.6; 95% CI, 1.0-2.4), and CKD (OR, 1.5; 95% CI, 1.0-2.3) at baseline were associated with having a high ABI, respectively. A high ABI was associated independently with elevated CV (HR, 2.6; 95% CI, 2.1-3.1; P < .0001) and all-cause mortality (HR, 2.5; 95% CI, 2.2-2.8; P < .0001) after adjusting for covariates, including diabetes, CKD, CAD, current smoking, cancer, and hypertension. Conclusions: A high ABI is associated with an elevated CV and all-cause mortality, similar to patients with PAD. High ABI participants should receive the same attention and aggressive medical therapies as patients with PAD. Competing Interests: Disclosures None. (Copyright © 2024. Published by Elsevier Inc.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu